|
Market Closed -
Sao Paulo
15:05:29 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 35.96 BRL | +6.55% |
|
+16.00% | -4.77% |
| 10-19 | CRISPR Therapeutics Names A.J. Silver as New Chief Financial Officer | MT |
| 10-19 | CRISPR Therapeutics AG Announces CFO Changes | CI |
| Market Cap | 5.23B 28.32B 4.69B 4.32B 3.91B 7.32B 498B 7.43B 51.58B 20.58B 261B 19.64B 19.22B 826B | P/E 2026 * |
-12.5x | P/E 2027 * | -16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.7B 20.03B 3.32B 3.06B 2.77B 5.18B 352B 5.26B 36.49B 14.56B 184B 13.89B 13.6B 584B | EV / Sales 2026 * |
91.5x | EV / Sales 2027 * | 26.4x |
| Free-Float |
93.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CRISPR Therapeutics AG
| 1 day | +6.55% | ||
| 1 week | +16.00% | ||
| Current month | +2.74% | ||
| 1 month | +2.16% | ||
| 3 months | +18.10% | ||
| 6 months | +17.02% | ||
| Current year | -4.77% |
| 1 week | 31 |  | 35.96 |
| 1 month | 31 | | 35.96 |
| Current year | 29.91 | | 40.04 |
| 1 year | 29.91 | | 43.4 |
| 3 years | 22.48 | | 55.26 |
| 5 years | 22.48 | | 58.4 |
| 10 years | 22.48 | | 58.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 47 | 2017-11-30 |
Andrew Silver
DFI | Director of Finance/CFO | 42 | 2026-10-18 |
Naimish Patel
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Simeon George
BRD | Director/Board Member | 49 | 2015-04-28 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2015-03-31 |
Samarth Kulkarni
CHM | Chairman | 47 | 2023-09-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.55% | +16.00% | - | - | 5.23B | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.26% | +12.91% | +82.98% | 55.53B | |
| +1.75% | +2.76% | +12.38% | +103.69% | 53.03B | |
| -1.43% | -0.57% | +26.10% | +52.86% | 45.99B | |
| -0.48% | -3.86% | +17.27% | +117.99% | 42.45B | |
| +0.82% | -2.06% | +227.09% | +922.41% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +44.58% | +102.84% | +88.74% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | +0.32% | +3.82% | +52.16% | +163.25% | 43.62B | |
| Weighted average by Cap. | -0.02% | +3.13% | +49.26% | +160.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 40.44M 219M 36.22M 33.42M 30.24M 56.54M 3.85B 57.46M 399M 159M 2.02B 152M 149M 6.38B | 154M 833M 138M 127M 115M 215M 14.66B 219M 1.52B 606M 7.67B 578M 566M 24.3B |
| Net income | -430M -2.33B -385M -355M -321M -601M -40.92B -611M -4.24B -1.69B -21.41B -1.61B -1.58B -67.82B | -339M -1.83B -303M -280M -253M -473M -32.24B -481M -3.34B -1.33B -16.88B -1.27B -1.24B -53.45B |
| Net Debt | -1.53B -8.28B -1.37B -1.26B -1.14B -2.14B -146B -2.17B -15.09B -6.02B -76.28B -5.74B -5.62B -242B | -1.17B -6.34B -1.05B -968M -876M -1.64B -112B -1.66B -11.55B -4.61B -58.38B -4.4B -4.3B -185B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | R$35.96 | +6.55% | 2 |
| 26-10-27 | R$33.75 | +8.87% | 20 |
| 26-10-23 | R$31.00 | -1.02% | 2 |
| 26-10-20 | R$31.32 | -0.95% | 35 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRSP Stock
- C2RS34 Stock
Select your edition
All financial news and data tailored to specific country editions
